Preliminary

A preliminary survey of the positions in the ICJ Climate Change advisory proceedings – EJIL: Talk! – Go Health Pro

by
A preliminary survey of the positions in the ICJ Climate Change advisory proceedings – EJIL: Talk! – Go Health Pro

Amongst the many legal issues arising from the ICJ advisory proceedings in Obligations of States in respect of Climate Change, the erga omnes nature of the obligations involved has a particular significance. This nature comprises not only strictly environmental obligations, but also human rights obligations related to climate change. The issue presents a singular opportunity … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more

Zacks Small Cap Research – RVPH: Preliminary OLE Readout – Go Health Pro

by
Zacks Small Cap Research – RVPH: Preliminary OLE Readout – Go Health Pro

By John Vandermosten, CFA NASDAQ:RVPH READ THE FULL RVPH RESEARCH REPORT Open Label Extension Initial Readout Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported preliminary results from its open label extension (OLE) portion of the Phase III RECOVER trial. Brilaroxazine showed a favorable long-term safety profile and improving efficacy over the one-year observation period. The schizophrenia candidate … Read more

x